Join
Live feed
·
NEWSReleasevia Quantisnow
Protagenic Therapeutics Inc. logo

Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTIX (Protagenic Therapeutics Inc.) and more on Quantisnow.